Loading clinical trials...
Loading clinical trials...
The combination therapy of temozolomide and radiation has been established as the standard therapy for the initial treatment of glioblastoma. However, the prognosis for patients with recurrent/ refrac...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Incheon St.Mary's Hospital
Collaborators
NCT07501559 · Recurrent Glioblastoma Multiforme(GBM)
NCT06616727 · Recurrent Glioblastoma Multiforme (GBM)
NCT00883298 · Recurrent Glioblastoma Multiforme, Recurrent Gliosarcoma
NCT00071539 · Recurrent Glioblastoma Multiforme
NCT00509301 · Recurrent Glioblastoma Multiforme
Ajou University Hospital
Wonchondong, Suwon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions